Similar articles

• [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].

  Kubo K, Karasawa A, Yamada K, Nito M, Shuto K, Nakamizo N. Kubo K, et al. Nihon Yakurigaku Zasshi. 1982 May;79(5):383-400. Nihon Yakurigaku Zasshi. 1982. PMID: 7129248 Japanese.
• Vasodilating effect of flunarizine in anesthetized dogs.

  Kato H, Kurihara J, Ishii K, Kasuya Y. Kato H, et al. Arch Int Pharmacodyn Ther. 1981 Feb;249(2):257-63. Arch Int Pharmacodyn Ther. 1981. PMID: 7224725
• [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].

  Ronchini P, D'Ambrosio E, Anesi E, Pellicioni P. Ronchini P, et al. G Clin Med. 1982 Feb;63(2):131-9. G Clin Med. 1982. PMID: 7106462 Italian. No abstract available.
• Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

  Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Holmes B, et al. Drugs. 1984 Jan;27(1):6-44. doi: 10.2165/00003495-198427010-00002. Drugs. 1984. PMID: 6141044 Review.
• Flunarizine in the treatment of vertigo.

  Wouters L, Amery W, Towse G. Wouters L, et al. J Laryngol Otol. 1983 Aug;97(8):697-704. doi: 10.1017/s0022215100094858. J Laryngol Otol. 1983. PMID: 6350513 Review.